Edluar Related Published Studies
Well-designed clinical trials related to Edluar (Zolpidem)
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. [2011.07]
The use of a non-benzodiazepine hypnotic sleep-aid (Zolpidem) in patients undergoing ACL reconstruction: a randomized controlled clinical trial. [2011.05]
Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects. [2011.04]
Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study. [2011.02.01]
A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia. [2011.01]
Influence of zolpidem and sleep inertia on balance and cognition during nighttime awakening: a randomized placebo-controlled trial. [2011.01]
Comparing effects of clonazepam and zolpidem on sleep quality of patients on
maintenance hemodialysis. [2011]
A double-blind, randomized, comparative study to evaluate the efficacy and safety
of zaleplon versus zolpidem in shortening sleep latency in primary insomnia. [2011]
Alterations in cyclic alternating pattern associated with phase advanced sleep are differentially modulated by gaboxadol and zolpidem. [2010.11]
Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep. [2010.11]
Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics. [2010.10]
Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. [2010.09]
Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia. [2010.06]
Modafinil and zolpidem use by emergency medicine residents. [2009.12]
Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers. [2009.07]
Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. [2009.06]
Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem. [2009.06]
Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study. [2009.06]
Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. [2009.05]
Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age. [2009.05]
A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T. [2009.05]
Improvement of idiopathic central sleep apnea with zolpidem. [2009.04.15]
Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects. [2009.02]
Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. [2008.12]
Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial. [2008.10.01]
Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings. [2008.09.01]
Use of computerized dynamic posturography to assess balance in older adults after nighttime awakenings using zolpidem as a reference. [2008.07.15]
Hypnotherapy in the treatment of chronic combat-related PTSD patients suffering from insomnia: a randomized, zolpidem-controlled clinical trial. [2008.07]
A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. [2008.06.15]
Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo. [2008.05]
Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. [2008.01.01]
A randomized, controlled prospective trial of zolpidem and haloperidol for use as sleeping agents in pediatric burn patients. [2008.01]
Efficacy and Safety of Zolpidem Extended Release in Elderly Primary Insomnia Patients. [2008.01]
Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate. [2008.01]
Evaluation of automated and semi-automated scoring of polysomnographic recordings from a clinical trial using zolpidem in the treatment of insomnia. [2007.11.01]
Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude. [2007.11.01]
Acute effects of zolpidem on daytime alertness, psychomotor and physical performance. [2007.11]
Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. [2007.07]
Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. [2007.07]
[Effects of paroxetine with or without zolpidem on depression with insomnia: a multi-center randomized comparative study] [2007.06.19]
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects. [2007.01]
Well-designed clinical trials possibly related to Edluar (Zolpidem)
Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. [2011.07]
Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users. [2011.05]
A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome. [2011.01]
MSLT in primary insomnia: stability and relation to nocturnal sleep. [2011]
Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor
agonist, in recreational polydrug users. [2011]
A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing. [2010.01]
Effect of hypnotic drugs on body balance and standing steadiness. [2010]
Validation of the sleep impact scale in patients with major depressive disorder and insomnia. [2009.07]
Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. [2009.05.20]
An evaluation of the neuroendocrine response to sleep in pediatric burn patients. [2009.05]
Differing effects of intracortical circuits on plasticity. [2009.03]
A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety. [2009.03]
Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia. [2009.02.15]
Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers. [2008.03]
Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy? [2008]
Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia. [2007.11]
Segregating two inhibitory circuits in human motor cortex at the level of GABAA receptor subtypes: A TMS study. [2007.10]
The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia. [2007.05.01]
A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers. [2007.05]
Other research related to Edluar (Zolpidem)
Differential effects of a dual orexin receptor antagonist (SB-649868) and
zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power
spectra in a model of situational insomnia. [2012]
The effect of zolpidem on sleep quality, stress status, and nondipping
hypertension. [2012]
EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem
in patients with primary insomnia. [2012]
Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal
symptoms: a prospective placebo-controlled study. [2012]
EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia. [2011.11.05]
Comparing effects of clonazepam and zolpidem on sleep quality of patients on maintenance hemodialysis. [2011.11]
Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. [2011.10.16]
Zolpidem dependence and withdrawal seizure--report of two cases. [2011.03]
Pregabalin in zolpidem dependence and withdrawal. [2011.03]
Effects of Alprazolam, Zolpidem and Zopiclone, and of chronic inflammation on peripheral experimental algesia in Wistar rats. [2011]
Zolpidem reduces the blood oxygen level-dependent signal during visual system
stimulation. [2011]
The use of a non-benzodiazepine hypnotic sleep-aid (Zolpidem) in patients
undergoing ACL reconstruction: a randomized controlled clinical trial. [2011]
Influence of zolpidem and sleep inertia on balance and cognition during nighttime
awakening: a randomized placebo-controlled trial. [2011]
Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy. [2010.09]
Zolpidem poisoning in a cat. [2010.08]
[Single and combining effects of Calculus Bovis and zolpidem on inhibitive neurotransmitter of rat striatum corpora] [2010.04]
Clinical and brain SPECT scan response to zolpidem in patients after brain damage. [2010]
Sublingual zolpidem in early onset of sleep compared to oral zolpidem:
polysomnographic study in patients with primary insomnia. [2010]
Zolpidem for persistent vegetative state--a placebo-controlled trial in
pediatrics. [2010]
Alterations in cyclic alternating pattern associated with phase advanced sleep
are differentially modulated by gaboxadol and zolpidem. [2010]
Augmentation of venlafaxine and selective serotonin reuptake inhibitors with
zolpidem improves sleep and quality of life in breast cancer patients with hot
flashes: a randomized, double-blind, placebo-controlled trial. [2010]
Mapping a barbiturate withdrawal locus to a 0.44 Mb interval and analysis of a novel null mutant identify a role for Kcnj9 (GIRK3) in withdrawal from pentobarbital, zolpidem, and ethanol. [2009.09.16]
Effect of zolpidem on the sleep arousal response to nocturnal esophageal acid exposure. [2009.09]
A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients. [2009.08]
Pharmacokinetics, pharmacodynamics and the pharmacokinetic/pharmacodynamic relationship of zolpidem in healthy subjects. [2009.07.31]
Paradoxical effects of the hypnotic Zolpidem in the neonatal ferret. [2009.07.19]
Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep. [2009.06.01]
Zolpidem in fatigue management for surge operations of remotely piloted aircraft. [2009.06]
Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam. [2009.06]
Novel zolpidem formulations. [2009.05]
Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. [2009.05]
Other possibly related research studies
Catatonia recognition and treatment. [2009.08]
A fatal case of benzodiazepine withdrawal. [2009.06]
Sleepwalking in psychiatric patients: comparison of childhood and adult onset. [2009.05]
5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia. [2010.08]
Medication Use and Functional Status Decline in Older Adults: A Narrative Review. [2011.11.04]
Predicting which medication classes interfere with allergy skin testing. [2010.11]
Fast network oscillations in vitro exhibit a slow decay of temporal auto-correlations. [2011.08]
Akathisia induced by gabapentin withdrawal. [2011.06]
Eszopiclone stimulates the hypothalamo-pituitary-adrenal axis in the rat. [2011.07.01]
Are hypnotic benzodiazepine receptor agonists teratogenic in humans? [2011.06]
|
